Novo Nordisk regains crown as Europe’s most valuable company
Drugmaker Novo Nordisk is once again Europe’s largest company by market capitalisation, rising above German software firm SAP on Friday.
Related Articles
Taking lessons from Ukraine, Taiwan eyes sea drones to counter China
Just off the small Taiwan fishing port of Wushi on its Pacific coast, a Taiwanese company is testing what could eventually be a powerful but…
India’s Sun Pharma names Kirti Ganorkar as managing director
Sun Pharmaceutical , India’s largest drugmaker by revenue, on Friday named Kirti Ganorkar as managing director, effective September 1.
Novo Nordisk regains crown as Europe’s most valuable company
Drugmaker Novo Nordisk is once again Europe’s largest company by market capitalisation, rising above German software firm SAP on Friday.
India’s Sun Pharma names Kirti Ganorkar as managing director
Sun Pharmaceutical , India’s largest drugmaker by revenue, on Friday named Kirti Ganorkar as managing director, effective September 1.
India’s Sun Pharma names Kirti Ganorkar as managing director
India’s Sun Pharmaceutical on Friday named Kirti Ganorkar as managing director, effective September 1, for a period of five years.
Russia says Israel’s attack on Iran was unprovoked and illegal
Russia said on Friday that Israeli strikes on Iran were unprovoked and in breach of the United Nations charter, accusing Israel of wrecking diplomatic efforts…
US says China’s Huawei can’t make more than 200,000 AI chips in 2025
China’s Huawei Technologies [RIC:RIC:HWT.UL] is capable of producing no more than 200,000 advanced artificial intelligence chips in 2025, a top U.S. exports controls official told…
Novo Nordisk regains crown as Europe’s most valuable company
Drugmaker Novo Nordisk is once again Europe’s largest company by market capitalisation, rising above German software firm SAP on Friday.
Mexico’s low-cost Similares pharmacy chain expands into vet care
Mexican pharmacy chain Farmacias Similares has expanded into veterinary care with the opening of its first on-site pet clinic, the company said on Thursday.
Novo Nordisk plans to start late-stage trials of obesity drug amycretin next year
Novo Nordisk said on Thursday it plans to start late-stage trials of its experimental weight-loss drug, amycretin, in injection and oral forms during the first…